These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2892589)

  • 41. Characteristics of the antihistamine effect of TAK-427, a novel imidazopyridazine derivative.
    Fukuda S; Midoro K; Yamasaki M; Gyoten M; Kawano Y; Fukui H; Ashida Y; Nagaya H
    Inflamm Res; 2003 May; 52(5):206-14. PubMed ID: 12813625
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Antiallergic effect of MY-5116 and its major metabolite, MY-1250].
    Kohno SW; Ohata K
    Arerugi; 1986 Nov; 35(11):1105-12. PubMed ID: 2435266
    [No Abstract]   [Full Text] [Related]  

  • 43. Determination of mizolastine, a new antihistaminic drug, in human plasma by liquid-liquid extraction, solid-phase extraction and column-switching techniques in combination with high-performance liquid chromatography.
    Ascalone V; Guinebault P; Rouchouse A
    J Chromatogr; 1993 Sep; 619(2):275-84. PubMed ID: 7903309
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Histaminopexic action of the serum].
    Sakano R
    Arerugi; 1970 Oct; 19(10):762-9. PubMed ID: 4097750
    [No Abstract]   [Full Text] [Related]  

  • 45. In vitro and in vivo studies of the non-sedating antihistamine epinastine.
    Fügner A; Bechtel WD; Kuhn FJ; Mierau J
    Arzneimittelforschung; 1988 Oct; 38(10):1446-53. PubMed ID: 2461715
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of the histamine-H1 antagonist astemizole on bronchoconstriction in the guinea-pig.
    Schuurkes JA; Van Nueten JM
    Arch Int Pharmacodyn Ther; 1983 Sep; 265(1):164-6. PubMed ID: 6139982
    [No Abstract]   [Full Text] [Related]  

  • 47. Mizolastine: antihistaminic activity from preclinical data to clinical evaluation.
    Simons FE
    Clin Exp Allergy; 1999 Mar; 29 Suppl 1():3-8. PubMed ID: 10209699
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Studies on an unusual N-dealkylation reaction. I. In vivo and in vitro N-dealkylation of N-t-butylnorchlorcyclizine to norchlorcyclizine by the rat.
    Kamm JJ; Szuna A; Kuntzman R
    J Pharmacol Exp Ther; 1972 Sep; 182(3):507-14. PubMed ID: 4403434
    [No Abstract]   [Full Text] [Related]  

  • 49. Antiallergic effect of trimetoquinol analogs on actively sensitized guinea pig lung tissue, in vitro.
    Mukhopadhyay A; Miller DD; Feller DR
    Biochem Pharmacol; 1986 Sep; 35(17):2977-9. PubMed ID: 2427089
    [No Abstract]   [Full Text] [Related]  

  • 50. Gas chromatographic method for the determination of cetirizine in plasma.
    Baltes E; Coupez R; Brouwers L; Gobert J
    J Chromatogr; 1988 Aug; 430(1):149-55. PubMed ID: 2905705
    [No Abstract]   [Full Text] [Related]  

  • 51. Objective rhinomanometric clinical testing of an antihistamine (clemastine) combined with adrenergic substance (phenylpropanolamine).
    Aschan G; Tham R
    Can J Otolaryngol; 1974; 3(4):577-80. PubMed ID: 4154136
    [No Abstract]   [Full Text] [Related]  

  • 52. H1 antihistamines: perspective on the use of the conventional and new agents.
    Drouin MA
    Ann Allergy; 1985 Nov; 55(5):747-52. PubMed ID: 2865918
    [No Abstract]   [Full Text] [Related]  

  • 53. Metabolism of picumast after administration of picumast dihydrochloride and antiallergic activity of the main metabolites.
    Besenfelder E; Neubert P; Roesch A; Schaumann W; Wilhelms OH
    Arzneimittelforschung; 1989 Oct; 39(10A):1317-20. PubMed ID: 2576355
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of E-4716, a new antihistaminic with antiallergic properties, on chemical mediators induction of immunologic reactions.
    Gutiérrez B; Dordal A; Fort M; Galicia J; Farré AJ
    Methods Find Exp Clin Pharmacol; 1996; 18(6):397-406. PubMed ID: 8892269
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Non-sedative antihistaminics and binding to central and peripheral H1 histamine receptors].
    Leysen JE; Gommeren W; Janssen PF; Sanz G; Gillardin JM; Schotte A; Janssen PA
    Allerg Immunol (Paris); 1991 Feb; 23(2):51-7. PubMed ID: 1677249
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inhibition of chemical mediator release from human leukocytes and lung in vitro by a novel antiallergic agent, KB-2413.
    Nishimura N; Ito K; Tomioka H; Yoshida S
    Immunopharmacol Immunotoxicol; 1987; 9(4):511-21. PubMed ID: 2449488
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A rapid method for the determination of diphenhydramine in plasma.
    Baugh R; Calvert RT
    Br J Clin Pharmacol; 1976 Dec; 3(6):1062-4. PubMed ID: 22216532
    [No Abstract]   [Full Text] [Related]  

  • 58. 2,3-Dihydro-2-oxo-1H-benzimidazole-1-carboxamides with selective affinity for the 5-HT(4) receptor: synthesis and structure-affinity and structure-activity relationships of a new series of partial agonist and antagonist derivatives.
    Tapia I; Alonso-Cires L; López-Tudanca PL; Mosquera R; Labeaga L; Innerárity A; Orjales A
    J Med Chem; 1999 Jul; 42(15):2870-80. PubMed ID: 10425096
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Probing ligand-specific histamine H1- and H2-receptor conformations with NG-acylated Imidazolylpropylguanidines.
    Xie SX; Ghorai P; Ye QZ; Buschauer A; Seifert R
    J Pharmacol Exp Ther; 2006 Apr; 317(1):139-46. PubMed ID: 16394198
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Interactions between histamine H1 receptor and its antagonists by using cell membrane chromatography method.
    Ma W; Zhang D; Li J; Che D; Liu R; Zhang J; Zhang Y
    J Pharm Pharmacol; 2015 Nov; 67(11):1567-74. PubMed ID: 26147217
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.